Cargando…

Correction to ‘Control of backbone chemistry and chirality boost oligonucleotide splice switching activity’

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123095/ https://www.ncbi.nlm.nih.gov/pubmed/36912093 http://dx.doi.org/10.1093/nar/gkad185

Ejemplares similares

Control of backbone chemistry and chirality boost oligonucleotide splice switching activity
por: Kandasamy, Pachamuthu, et al.
Publicado: (2022)

Synthesis of Backbone-Modified Morpholino Oligonucleotides Using Phosphoramidite Chemistry
por: Paul, Sibasish, et al.
Publicado: (2023)

Interplay of polyethyleneimine molecular weight and oligonucleotide backbone chemistry in the dynamics of antisense activity
por: Sundaram, Sumati, et al.
Publicado: (2007)

Anti-tumor activity of splice-switching oligonucleotides
por: Bauman, John A., et al.
Publicado: (2010)

Splice-switching antisense oligonucleotides as therapeutic drugs
por: Havens, Mallory A., et al.
Publicado: (2016)

Oligonucleotide analogues with cationic backbone linkages
por: Meng, Melissa, et al.
Publicado: (2018)

Intravitreal Injection of Splice-switching Oligonucleotides to Manipulate Splicing in Retinal Cells
por: Gérard, Xavier, et al.
Publicado: (2015)

A framework for individualized splice-switching oligonucleotide therapy
por: Kim, Jinkuk, et al.
Publicado: (2023)

Lipophilic Peptide Dendrimers for Delivery of Splice-Switching Oligonucleotides
por: Daralnakhla, Haneen, et al.
Publicado: (2021)

Fructose Promotes Uptake and Activity of Oligonucleotides with Different Chemistries in a Context-Dependent Manner in mdx Mice
por: Cao, Limin, et al.
Publicado: (2020)

Open reading frame correction using splice-switching antisense oligonucleotides for the treatment of cystic fibrosis
por: Michaels, Wren E., et al.
Publicado: (2022)

Oligonucleotide–Palladacycle Conjugates as Splice-Correcting Agents
por: Hande, Madhuri, et al.
Publicado: (2019)

Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oligonucleotides
por: Järver, Peter, et al.
Publicado: (2015)

Hybridization-mediated off-target effects of splice-switching antisense oligonucleotides
por: Scharner, Juergen, et al.
Publicado: (2020)

Induction of cryptic pre-mRNA splice-switching by antisense oligonucleotides
por: Ham, Kristin A., et al.
Publicado: (2021)

Author Correction: Extracting backbones in weighted modular complex networks
por: Ghalmane, Zakariya, et al.
Publicado: (2021)

Correction: A Tandem Oligonucleotide Approach for SNP-Selective RNA Degradation Using Modified Antisense Oligonucleotides
por: Magner, Dorota, et al.
Publicado: (2016)

Correction: Estrogen receptor beta signaling in CD8+ T cells boosts T cell receptor activation and antitumor immunity through a phosphotyrosine switch
Publicado: (2021)

Covalently attached intercalators restore duplex stability and splice-switching activity to triazole-modified oligonucleotides
por: Dysko, Anna, et al.
Publicado: (2022)

Modulation of MKNK2 alternative splicing by splice-switching oligonucleotides as a novel approach for glioblastoma treatment
por: Mogilevsky, Maxim, et al.
Publicado: (2018)

Design and evaluation of locked nucleic acid-based splice-switching oligonucleotides in vitro
por: Shimo, Takenori, et al.
Publicado: (2014)

Antisense Oligonucleotide-Mediated Splice Switching: Potential Therapeutic Approach for Cancer Mitigation
por: Raguraman, Prithi, et al.
Publicado: (2021)

Palmitic acid conjugation enhances potency of tricyclo-DNA splice switching oligonucleotides
por: Relizani, Karima, et al.
Publicado: (2021)

Correction: Investigations of Oligonucleotide Usage Variance Within and Between Prokaryotes
por: Bohlin, Jon, et al.
Publicado: (2009)

Correction: Investigations of Oligonucleotide Usage Variance Within and Between Prokaryotes
por: Bohlin, Jon, et al.
Publicado: (2009)

Correction: Investigations of Oligonucleotide Usage Variance Within and Between Prokaryotes
por: Bohlin, Jon, et al.
Publicado: (2009)

Correction: Investigations of Oligonucleotide Usage Variance Within and Between Prokaryotes
por: Bohlin, Jon, et al.
Publicado: (2009)

Correction: Investigations of Oligonucleotide Usage Variance Within and Between Prokaryotes
por: Bohlin, Jon, et al.
Publicado: (2009)

Impact of guanidine-containing backbone linkages on stereopure antisense oligonucleotides in the CNS
por: Kandasamy, Pachamuthu, et al.
Publicado: (2022)

Targeting novel human transient receptor potential ankyrin 1 splice variation with splice-switching antisense oligonucleotides
por: Huang, Hua, et al.
Publicado: (2021)

Correlating In Vitro Splice Switching Activity With Systemic In Vivo Delivery Using Novel ZEN-modified Oligonucleotides
por: Hammond, Suzan M, et al.
Publicado: (2014)

Sugar and Polymer Excipients Enhance Uptake and Splice-Switching Activity of Peptide-Dendrimer/Lipid/Oligonucleotide Formulations
por: Saher, Osama, et al.
Publicado: (2019)

Correction to: An overview of chiral separations of pharmaceutically active substances by HPLC (2018–2020)
por: Grybinik, Sofiya, et al.
Publicado: (2021)

Boosting Semantic Segmentation by Conditioning the Backbone with Semantic Boundaries
por: Ishikawa, Haruya, et al.
Publicado: (2023)

Mismatched single stranded antisense oligonucleotides can induce efficient dystrophin splice switching
por: Fragall, Clayton T, et al.
Publicado: (2011)

The small molecule Retro-1 enhances the pharmacological actions of antisense and splice switching oligonucleotides
por: Ming, Xin, et al.
Publicado: (2013)

7′,5′-alpha-bicyclo-DNA: new chemistry for oligonucleotide exon splicing modulation therapy
por: Evéquoz, Damien, et al.
Publicado: (2021)

Publisher Correction: Intensity-dependent modulation of optically active signals in a chiral metamaterial
por: Rodrigues, Sean P., et al.
Publicado: (2018)

Correction: Inherently chiral calix[4]arenes via oxazoline directed ortholithiation: synthesis and probe of chiral space
por: Herbert, Simon A, et al.
Publicado: (2017)

Splice-Switching Antisense Oligonucleotides Reduce LRRK2 Kinase Activity in Human LRRK2 Transgenic Mice
por: Korecka, Joanna A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_34c5lolsm19nrsn5bou9jjpv3u